Showing results (11-20 of 26) with videos related to

Sort By:
Pageof 3
Journal of Hepatocellular Carcinoma|March 4, 2026
Gustave Roussy Immune Score Predicts Outcomes in Hepatocellular Carcinoma Treated with TACE and ImmunotherapyLihao Qin, Xiao-Yang Xu, Hao Yang, et al.
Toxicology|August 24, 2013
Toll-like receptor 4 is involved in myocardial damage following paraquat poisoning in miceXue-Song Dong, Xiao-Yang Xu, Yu-Qiang Sun, et al.
Sheng Li Xue Bao : [Acta Physiologica Sinica]|March 5, 2021
[Short-chain fatty acid butyrate acid attenuates atherosclerotic plaque formation in apolipoprotein E-knockout mice and the underlying mechanism]Hong-Bo Bai, Ping Yang, Han-Bin Zhang, et al.
Experimental Biology and Medicine (Maywood, N.J.)|June 4, 2020
CircFADS2: A potential prognostic biomarker of colorectal cancerYi-Sheng Xiao, Hua-Zhang Tong, Xi-Hong Yuan, et al.
Journal of Alternative and Complementary Medicine (New York, N.Y.)|October 20, 2010
Effect of slow abdominal breathing combined with biofeedback on blood pressure and heart rate variability in prehypertensionShu-Zhen Wang, Sha Li, Xiao-Yang Xu, et al.
Frontiers in Physiology|August 17, 2019
Endurance Training Counteracts the High-Fat Diet-Induced Profiling Changes of ω-3 Polyunsaturated Fatty Acids in Skeletal Muscle of Middle-Aged RatsTing Li, Ding-Guo Ruan, Zhen-Mao Lin, et al.
Oncotargets and Therapy|July 24, 2018
Downregulation and DNA methylation of ECRG4 in gastric cancerPeng Deng, Xiao-Jing Chang, Zi-Ming Gao, et al.
Chinese Journal of Integrative Medicine|December 29, 2016
Multi-drug resistant uropathogenic Escherichia coli and its treatment by Chinese medicineShi-Wei Liu, Xiao-Yang Xu, Jie Xu, et al.
Nan Fang Yi Ke Da Xue Xue Bao = Journal of Southern Medical University|July 13, 2018
[AMPK regulates mitochondrial oxidative stress in C2C12 myotubes induced by electrical stimulations of different intensities]He-Ling Dong, Hong-Yuan Wu, Yu Tang, et al.
Therapeutic Advances in Medical Oncology|July 3, 2025
Liver function dynamics in advanced hepatocellular carcinoma receiving immune checkpoint inhibitors and anti-vascular endothelial growth factor antibody/tyrosine kinase inhibitors with or without transarterial chemoembolizationChen-You Liu, Meng-Fan Wang, Xiao-Yang Xu, et al.
Pageof 3